ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: King Faisal Prize Next Year Will Be Awarded For Leukemia Research; Yarbro Wins Fulbirght

March 20, 1987

NCI Using Three Methods To Encourage Grants In Programs

August 25, 1978

Perot Systems To Provide IT Support For US Oncology Enterprise Applications.

December 15, 2000

Trials Approved In October

December 28, 2001

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011